OUR EXPERIENCE
6
Years of
clinical experience
8
Robust, controlled, and independent clinical studies
100+
Healthcare facilities
users of the solution
OUR MISSION
To design, develop, and deliver digital therapy solutions validated by robust and independent clinical studies, serving both caregivers and patients.
To digitalize care and make it accessible to all by providing a concrete, effective, and secure response to the management of pain and anxiety.
To provide healthcare professionals with reliable, practical tools that simplify the patient care pathway.
OUR AMBITION
01 Enhancing the management of pain and anxiety.
02 Providing innovative, alternative, and complementary solutions to conventional therapy.
03 Improving the care pathway from both organizational and economic perspectives.
OUR SOLUTION · VIRTUAL REALITY TO TREAT PAIN AND ANXIETY
Our immersive and immediate digital sedation solution
Bliss DTx, a Class I CE-marked medical device, is an immersive solution designed to support patients before, during, and after painful and/or anxiety-inducing medical procedures.
It is used either as an adjunct to or as a substitute for traditional pharmacological products and medical gases.
The solution immerses patients in sound and visual environments that engage their capacities and place them in a modified state of consciousness, significantly reducing the perceived level of pain.
Complementary to medication, Bliss DTx is designed as a universal solution accessible to all patients, without social or language barriers.
VR headset
PAIN
ANXIETY
Bliss DTx, a medical, organizational and economic benefit
Before the gesture
The option of local or regional anesthesia rather than general anesthesia
A direct positive impact on resource utilization: nursing cost and time
During the gesture
An alternative to the use of medical gas in pain management, with limited side effects
A direct positive impact on resource utilization: nursing cost and time
After the gesture
A possible exclusion or limitation of access to the recovery room
A faster return to the room without a stretcher
A direct positive impact on resource utilization: cost, nursing time, and faster patient turnover in the recovery room
Bliss DTx,
possible applications
in the management of pain and anxiety
01 During diagnostic and sampling procedures (biopsy, lumbar puncture, etc.)
02 During painful and anxiety-inducing procedures such as dressing changes in geriatric care, for patients with severe burns, etc.
03 During surgical procedures carried out under local anaesthesia (Port-a-Cath surgery, endovenous thermal treatment of varicose veins, etc.)
OUR CLINICAL EVIDENCE · REVEH STUDY
Bliss DTx compared to MEOPA during bone marrow biopsy
Study objective
Evaluate the efficacy and safety of Bliss DTx compared to MEOPA*, in the prevention of pain during a bone marrow biopsy.
Methodology
126 patients included in a multicenter, randomized, phase III study.
Security
No adverse events occurred during the biopsy in the Bliss DTx group.
Primary endpoint
No significant difference in pain intensity (p = 0.26) between the MEOPA group and the Bliss DTx group.
Secondary endpoint
Physician satisfaction was significantly higher
(p = 0.01) with the use of Bliss DTx compared to MEOPA.
Pain intensity assessed using the Visual Analog Scale
(VAS, 0 = no pain, 10 = maximum imaginable pain)
Physician satisfaction
Non-inferiority of Bliss DTx compared to MEOPA in preventing pain during bone marrow biopsies
* MEOPA is a medical gas used for its anxiolytic and analgesic properties. It is an equimolar mixture of oxygen and nitrous oxide.
OUR PRODUCTS IN DEVELOPMENT
Endocare DTx,
our solution dedicated to endometriosis
An innovative alternative for better living with endometriosis
Endocare DTx is a new medical device based on immersive digital therapy.
It is designed to support women suffering from chronic pelvic pain associated with endometriosis.
By combining sensory neurostimulation, deep relaxation and hypnotic suggestion, Endocare DTx offers an innovative and effective alternative with minimal side effects.
The efficacy and safety of our solution have been validated in two randomised, controlled clinical trials.
OUR KEY PUBLICATIONS
Innovation, rigor and scientific proof
2023 · Bliss DTx
A new option in pain prevention with bliss, a therapeutic virtual reality solution in bone marrow biopsy context: (REVEH Trial)
Katell LE DU, Anne-Lise Septans, Frédéric Maloisel and al.
2022 · Endocare
Pain Reduction With an Immersive Digital Therapeutic Tool in Women Living With Endometriosis-Related Pelvic Pain: Randomized Controlled Trial
Benjamin Merlot, Garance Dispersyn, Zoé Husson and al.
2023 · Endocare
Pain Reduction With an Immersive Digital Therapeutic in Women Living With Endometriosis-Related Pelvic Pain: At-Home Self-Administered Randomized Controlled Trial
Benjamin Merlot, Valéry Elie and al
OUR TEAM
Experts coming together to focus on care
Epidemiologists, oncologists, angiologists, engineers and IT specialists: the complementary nature of our expertise is our strength. Together, we develop rigorous solutions centred on the clinician and their patient.
By combining scientific, medical and technological expertise, we are exploring new avenues to improve care pathways for patients experiencing pain and anxiety.
CONTACT
Contact us
To discover our solutions , customize your needs , and discuss with our teams
72530 Yvré-L'Evêque, France
198 Avenue de France
75013 Paris, France
